Marken Strengthens Clinical Trial Distribution Capabilities

Marken Strengthens Clinical Trial Distribution Capabilities

Dr. Andrea Zobel joins Marken's expanding team of Clinical Supply Chain experts

LONDON, Jan. 10, 2012 /PRNewswire/ -- Marken is pleased to announce that Dr. Andrea Zobel has joined Marken in the new role of Senior Director, CTD Operations. In this capacity she will assume responsibility for all activities within the growing network of Marken operated Clinical Trial Depots once they are completed and qualified for use and also manage the relationship with their affiliate depot network.

Dr. Zobel is a biochemist by training and spent her early career in drug development as an assistant professor at the Institute for Pharmacology, Freie Universitat Berlin then as Head of Preclinical Development at ActinoDrug Pharmaceuticals, Henningsdorf. Since 2004 Andrea has worked for Parexel International building unparalleled experience as Director Clinical Logistics Europe and Head of Global Center of Excellence Clinical Trial Supply both building and running a business with annual revenues in excess of USD 50 million. She has a deep knowledge of managing strategic partnerships within the pharmaceutical industry, specialist knowledge in managing clinical trials logistics worldwide but particularly within Europe and a passion for professional Project Management.

"We are excited to welcome Andrea to our team, her expertise and knowledge of the industry further strengthens the market leadership of Marken's Clinical Trial Distribution service line," Marken CEO, Wes Wheeler commented. "Our continued enhancement of our purpose build Pharmaceutical Service Depot network establishes Marken as the clear choice for innovative global clinical supply chain solutions."

Marken the premium provider of life science logistics solutions reinforces its commitment to the Clinical Trial Distribution (CTD) business by accelerating the creation of their global network of Clinical Trial Depots. The company plans to expand its current network of depots to 12 fully owned and operated facilities in 2012 and is supported by an extensive network of third party service providers.

Andrea will be based in the new Marken Berlin office which is scheduled to begin operation in the first quarter of 2012.

About Marken
Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.

SOURCE Marken

RELATED LINKS
http://www.marken.com

 

Suggested Articles

New real-world data from Lilly and BI show their SGLT2 med Jardiance topped GLP-1s at preventing heart failure hospitalization.

Following its headline-grabbing presentation at ESC, AZ is out with more data that support Farxiga use in non-diabetic heart failure patients.

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.